Corporate Information

Description of the business

Please click on the links below for a description of the business and strategy.
Company Overview      Investing Policy

 

The names of the directors and biographical details

Please click on the link below for the names and brief biographical details of each director. 
Directors

 

Directors' responsibilities

Please click on the link below for details on the directors' responsibilities. 
Corporate Governance

 

Board committees

Please click on the link below for details of OKYO Pharma's Board committees. 
Corporate Governance

 

Country of incorporation and main country of operation

OKYO Pharma is incorporated and registered in Guernsey with company number 65220. OKYO Pharma's main country of operation is the United Kingdom. Please click on the link below for the Memorandum and the Articles of Association. 
Corporate Documents

 

Details of any other exchanges or trading platforms

OKYO Pharma is not listed on any other exchanges or trading platforms.

 

Number of securities in issue

Please click on the link below for details of the number of securities in issue, the number of securities held as treasury shares and, insofar as OKYO Pharma is aware, the percentage of securities that is not in public hands together with the identity and percentage holdings of significant shareholders.
Share Information

 

Details of any restrictions on the transfer of securities

There are no restrictions on the transfer of securities.

 

Financial information

Please click on the link below for access to OKYO Pharma's annual and interim reports.
Annual & Interim Reports

 

Company announcements

Please click on the link below to access notifications made by OKYO Pharma in the past 12 months. 
News

 

Admission documents and circulars

Please click on the appropriate links below to access:
Prospectus dated 12 July 2018
Standard List Prospectus

Proposed Cancellation, Suspension and Notice of General Meeting Document 21 February 2018

Document

Admission Document dated 20 December 2011
AIM Admission Document

Admission Document dated 25 June 2008
AIM Admission Document

Notice of Annual General Meeting dated 16 September 2011
AGM Notice

Notice of Meeting of Shareholders dated 23 March 2011
Notice of Meeting of Shareholders

Notice of Annual General Meeting dated 24 September 2010
AGM Notice

Notice of Annual General Meeting dated 8 July 2009
AGM Notice

Notice of Meeting of Shareholders dated 1 April 2009
Notice of Meeting of Shareholders

 

Advisers

Please click on the link below for details of OKYO Pharma's key advisers. 
Corporate Directory

 

ISIN

Please note that OKYO Pharma's ISIN number is GG00BD3FV870.

 

Page last updated 13 July 2018.